Loading...
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial
PURPOSE: Hepatitis C virus (HCV) infection is a major healthcare concern in Russia, where almost 5 million individuals are viremic. Elbasvir/grazoprevir is a fixed-dose combination therapy for the treatment of HCV genotype 1 and genotype 4 infection. The present analysis aimed to assess the safety a...
Na minha lista:
| Udgivet i: | Hepat Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7183329/ https://ncbi.nlm.nih.gov/pubmed/32368162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HMER.S241418 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|